Pharmafile Logo
Pharmafocus logo
Advanced Search

Brain implant can lift severe depression, study finds

October 5, 2021
Manufacturing and Production, Research and Development

Researchers from the University of California have created an electrical implant that sits in the skull, wired to the brain, …

News

NICE recommends first new sickle cell disease treatment in 20 years

October 5, 2021
Manufacturing and Production, Medical Communications, Research and Development

NICE has announced on Tuesday that for the first time in 20 years, a new treatment will be made available …

News
1109181692_a148e995c4_c

AlzeCure’s Alzheimer project initiates Phase I study

October 4, 2021
Sales and Marketing

Swedish pharmaceutical company AlzeCure Pharma AB has announced the initiation of the company’s next clinical Phase I trial (multiple ascending …

News

SEED invests in CBD brand business

October 4, 2021
Sales and Marketing

SEED Innovations Ltd has announced that it has invested a further £150,000 in South West Brands Limited (SWB), a multi-brand …

News

Bayer Phase III trial results prove positive for diabetes patients

October 4, 2021
Sales and Marketing

Bayer has revealed positive results from their FIGARO-DKD Phase III trial of Kerendia (finerenone), which showcased the drug’s ability to …

News

Eli Lilly and India’s Cipla enter deal on diabetes treatments

October 4, 2021
Business Services, Sales and Marketing

Eli Lilly and Mumbai-based Cipla have announced a deal in which Cipla will sell and distribute two of Lilly’s best-selling …

News
az

FDA grants BTD for Daiichi Sankyo and AstraZeneca’s Enhertu

October 4, 2021
Research and Development, Sales and Marketing

AstraZeneca and Daiichi Sankyo have today announced that the FDA has granted Enhertu (fam-trastuzumab deruxtecan-nxki) breakthrough therapy designation (BTD) for …

News

Faron raises over €10mln to support key drug candidates

October 1, 2021
Medical Communications

Clinical stage biopharmaceutical company, Faron, has raised €10.5mln through a placing of new shares backed by the European Innovation Council …

News

Delta variant found to be common in children across US

October 1, 2021
Medical Communications

School-aged children across the US are being exposed to the increasingly prevalent Delta variant of COVID-19. This is linked to …

News

New Gyros kit supports cell and gene therapy

October 1, 2021
Medical Communications

Gyros Protein Technologies, leading provider of peptide synthesisers and reagents, has introduced the Gyrolab® AAV9 Titer Kit to support AAV-based …

News

Takeda: Stainless steel COVID vaccine contamination due to human error

October 1, 2021
Medical Communications

Takeda has said that “human error” led to metal contaminants being present in Moderna’s COVID-19 vaccine doses, which caused around …

News

GSK and Merck KGaA end collaboration on cancer drug hopeful

October 1, 2021
Medical Communications

GSK and German based Merck KGaA announced on Thursday that they have ended their collaboration on cancer treatment bintrafusp alfa, …

News

EADV reveals vaccine hesitancy in psoriasis patients

September 30, 2021
Business Services

Research presented at the European Academy of Dermatology and Venerology (EADV) 30th Congress has revealed that psoriasis and psoriatic arthritic …

News

Nanoform granted funding to tackle global health challenges

September 30, 2021
Business Services

Innovative nanoparticle medicine company, Nanoform, has announced that proof of concept studies will receive funding from the Bill & Melinda …

News

MSD pioneers gender-neutral HPV vaccine in India

September 30, 2021
Business Services

MSD Pharmaceuticals has announced the launch of India’s first gender-neutral Human Papillomavirus (HPV) vaccine, according to ABP Live. The aim …

News

Study finds coming off antidepressants may not cause relapse

September 30, 2021

Researchers from the universities of York, Southampton, and Bristol, UCL, and McMaster University in Canada, have been investigating the impacts …

News

Mirum’s Livmarli becomes first US approved Alagille syndrome treatment

September 30, 2021

Mirum Pharmaceutical’s oral drug has become the first approved treatment for treating itching in patients with a rare liver disorder …

News

Avacta reaches milestone in LG Chem partnership

September 29, 2021
Research and Development

Clinical stage biopharmaceutical company, Avacta Group plc, has announced that a preclinical development milestone has been achieved in the partnership …

News
39736431593_abc529f43d_c

Novartis autoinjector effective for treating psoriasis

September 29, 2021
Research and Development

New data show that Novartis Cosentyx (secukinumab) 300-mg single dose autoinjector resulted in high efficacy vs placebo. Cosentyx is a …

News
white-shutterstock_71287333

Acacia Pharma’s new cancer care injection approved in Europe

September 29, 2021
Research and Development

Biopharmaceutical company Acacia Pharma Group plc (Acacia Pharma) has announced that its Marketing Authorisation Application (MAA) for BARHEMSYS® (amisulpride injection) …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025